Related references
Note: Only part of the references are listed.Genomic Analysis of Response to Neoadjuvant Chemotherapy in Esophageal Adenocarcinoma
Fereshteh Izadi et al.
CANCERS (2021)
In search of definitions: Cancer-associated fibroblasts and their markers
Martin Nurmik et al.
INTERNATIONAL JOURNAL OF CANCER (2020)
Visualizing and interpreting cancer genomics data via the Xena platform
Mary J. Goldman et al.
NATURE BIOTECHNOLOGY (2020)
A framework for advancing our understanding of cancer-associated fibroblasts
Erik Sahai et al.
NATURE REVIEWS CANCER (2020)
Antifibrotic Synergy Between Phosphodiesterase Type 5 Inhibitors and Selective Oestrogen Receptor Modulators in Peyronie's Disease Models
Marcus M. Ilg et al.
EUROPEAN UROLOGY (2019)
The landscape of selection in 551 esophageal adenocarcinomas defines genomic biomarkers for the clinic
Alexander M. Frankell et al.
NATURE GENETICS (2019)
Quantification of stromal reaction in breast carcinoma and its correlation with tumor grade and free progression survival
Xavier Catteau et al.
PLOS ONE (2019)
Blocking CXCR4 alleviates desmoplasia, increases T-lymphocyte infiltration, and improves immunotherapy in metastatic breast cancer
Ivy X. Chen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Cancer associated fibroblasts sculpt tumour microenvironment by recruiting monocytes and inducing immunosuppressive PD-1+ TAMs
Betul Gokyavuz et al.
SCIENTIFIC REPORTS (2019)
Human Pancreatic Carcinoma-Associated Fibroblasts Promote Expression of Co-inhibitory Markers on CD4+ and CD8+ T-Cells
Laia Gorchs et al.
FRONTIERS IN IMMUNOLOGY (2019)
Cancer-Associated Fibroblasts Build and Secure the Tumor Microenvironment
Tianyi Liu et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2019)
Phosphodiesterase 5 (PDE5) Is Highly Expressed in Cancer-Associated Fibroblasts and Enhances Breast Tumor Progression
Stefania Catalano et al.
CANCERS (2019)
Stromal-derived interleukin 6 drives epithelial-to-mesenchymal transition and therapy resistance in esophageal adenocarcinoma
Eva A. Ebbing et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Targeting of activated fibroblasts for imaging and therapy
Thomas Lindner et al.
EJNMMI RADIOPHARMACY AND CHEMISTRY (2019)
Targeting the Myofibroblastic Cancer-Associated Fibroblast Phenotype Through Inhibition of NOX4
Christopher J. Hanley et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2018)
Targeting the Myofibroblastic Cancer-Associated Fibroblast Phenotype Through Inhibition of NOX4
Christopher J. Hanley et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2018)
Quantitative proteomic profiling of primary cancer-associated fibroblasts in oesophageal adenocarcinoma
Antigoni Manousopoulou et al.
BRITISH JOURNAL OF CANCER (2018)
Fibroblast Heterogeneity and Immunosuppressive Environment in Human Breast Cancer
Ana Costa et al.
CANCER CELL (2018)
Pulmonary arterial hypertension: pathogenesis and clinical management
Thenappan Thenappan et al.
BMJ-BRITISH MEDICAL JOURNAL (2018)
Pulmonary arterial hypertension: pathogenesis and clinical management
Thenappan Thenappan et al.
BMJ-BRITISH MEDICAL JOURNAL (2018)
Is there a room for immune checkpoint inhibitors in early stage non-small cell lung cancer?
Elisa Gobbini et al.
JOURNAL OF THORACIC DISEASE (2018)
A robust response to combination immune checkpoint inhibitor therapy in HPV-related small cell cancer: a case report
Won Jin Ho et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2018)
Immune Therapeutics in the Treatment of Advanced Gastric and Esophageal Cancer
Robin Park et al.
ANTICANCER RESEARCH (2018)
Repurposing drugs in oncology (ReDO)-selective PDE5 inhibitors as anti-cancer agents
Pan Pantziarka et al.
ECANCERMEDICALSCIENCE (2018)
The histological quantification of alpha-smooth muscle actin predicts future graft fibrosis in pediatric liver transplant recipients
Sharat Varma et al.
PEDIATRIC TRANSPLANTATION (2017)
Individual patient oesophageal cancer 3D models for tailored treatment
John H. Saunders et al.
ONCOTARGET (2017)
Neoadjuvant cisplatin and fluorouracil versus epirubicin, cisplatin, and capecitabine followed by resection in patients with oesophageal adenocarcinoma (UK MRC OE05): an open-label, randomised phase 3 trial
Derek Alderson et al.
LANCET ONCOLOGY (2017)
Integrated genomic characterization of oesophageal carcinoma
Jihun Kim et al.
NATURE (2017)
QuPath: Open source software for digital pathology image analysis
Peter Bankhead et al.
SCIENTIFIC REPORTS (2017)
Exosomal microRNAs derived from colorectal cancer-associated fibroblasts: role in driving cancer progression
Rahul Bhome et al.
AGING-US (2017)
Multicentre cohort study to define and validate pathological assessment of response to neoadjuvant therapy in oesophagogastric adenocarcinoma
F. Noble et al.
BRITISH JOURNAL OF SURGERY (2017)
Neoadjuvant chemotherapy or chemoradiation for patients with advanced adenocarcinoma of the oesophagus? A propensity score-matched study
F. Favi et al.
EJSO (2017)
Pulmonary hemodynamics and effects of phosphodiesterase type 5 inhibition in heart failure: a meta-analysis of randomized trials
In-Chang Hwang et al.
BMC CARDIOVASCULAR DISORDERS (2017)
A subset of myofibroblastic cancer-associated fibroblasts regulate collagen fiber elongation, which is prognostic in multiple cancers
Christopher J. Hanley et al.
ONCOTARGET (2016)
Identification of the CIMP-like subtype and aberrant methylation of members of the chromosomal segregation and spindle assembly pathways in esophageal adenocarcinoma
Lutz Krause et al.
CARCINOGENESIS (2016)
3-Dimensional Patient-Derived Lung Cancer Assays Reveal Resistance to Standards-of-Care Promoted by Stromal Cells but Sensitivity to Histone Deacetylase Inhibitors
David Onion et al.
MOLECULAR CANCER THERAPEUTICS (2016)
Mutational signatures in esophageal adenocarcinoma define etiologically distinct subgroups with therapeutic relevance
Maria Secrier et al.
NATURE GENETICS (2016)
Tumor-induced stromal reprogramming drives lymph node transformation
Angela Riedel et al.
NATURE IMMUNOLOGY (2016)
Authentication and characterisation of a new oesophageal adenocarcinoma cell line: MFD-1
Edwin Garcia et al.
SCIENTIFIC REPORTS (2016)
Highly Parallel Genome-wide Expression Profiling of Individual Cells Using Nanoliter Droplets
Evan Z. Macosko et al.
CELL (2015)
Activators and stimulators of soluble guanylate cyclase counteract myofibroblast differentiation of prostatic and dermal stromal cells
Christoph Zenzmaier et al.
EXPERIMENTAL CELL RESEARCH (2015)
Cancer-associated fibroblasts predict poor outcome and promote periostin-dependent invasion in oesophageal adenocarcinoma
Timothy J. Underwood et al.
JOURNAL OF PATHOLOGY (2015)
Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial
Joel Shapiro et al.
LANCET ONCOLOGY (2015)
Spatial reconstruction of single-cell gene expression data
Rahul Satija et al.
NATURE BIOTECHNOLOGY (2015)
Whole-genome sequencing provides new insights into the clonal architecture of Barrett's esophagus and esophageal adenocarcinoma
Caryn S. Ross-Innes et al.
NATURE GENETICS (2015)
ClustVis: a web tool for visualizing clustering of multivariate data using Principal Component Analysis and heatmap
Tauno Metsalu et al.
NUCLEIC ACIDS RESEARCH (2015)
PDE5 inhibitors as therapeutics for heart disease, diabetes and cancer
Anindita Das et al.
PHARMACOLOGY & THERAPEUTICS (2015)
The Genotype-Tissue Expression (GTEx) pilot analysis: Multitissue gene regulation in humans
Kristin G. Ardlie et al.
SCIENCE (2015)
Ordering of mutations in preinvasive disease stages of esophageal carcinogenesis
Jamie M. J. Weaver et al.
NATURE GENETICS (2014)
Wdr66 is a novel marker for risk stratification and involved in epithelial-mesenchymal transition of esophageal squamous cell carcinoma
Qing Wang et al.
BMC CANCER (2013)
Pleiotropic actions of miR-21 highlight the critical role of deregulated stromal microRNAs during colorectal cancer progression
M. D. Bullock et al.
CELL DEATH & DISEASE (2013)
Phosphodiesterase Type 5 Inhibition Reverts Prostate Fibroblast-to-Myofibroblast Trans-Differentiation
Christoph Zenzmaier et al.
ENDOCRINOLOGY (2012)
Bone Marrow-Derived Myofibroblasts Contribute to the Mesenchymal Stem Cell Niche and Promote Tumor Growth
Michael Quante et al.
CANCER CELL (2011)
Stromal features are predictive of disease mortality in oral cancer patients
Daniel Marsh et al.
JOURNAL OF PATHOLOGY (2011)
A comparison of primary oesophageal squamous epithelial cells with HET-1A in organotypic culture
Timothy J. Underwood et al.
BIOLOGY OF THE CELL (2010)
A 4-Gene Signature Predicts Survival of Patients With Resected Adenocarcinoma of the Esophagus, Junction, and Gastric Cardia
Christopher J. Peters et al.
GASTROENTEROLOGY (2010)
Mesenchymal Stem Cells: Flip Side of the Coin
Pravin J. Mishra et al.
CANCER RESEARCH (2009)
The Relationship between Erectile Dysfunction and Lower Urinary Tract Symptoms and the Role of Phosphodiesterase Type 5 Inhibitors
Tobias S. Koehler et al.
EUROPEAN UROLOGY (2009)
Long-Term Results of a Randomized Trial of Surgery With or Without Preoperative Chemotherapy in Esophageal Cancer
William H. Allum et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
CtBPs Promote Cell Survival through the Maintenance of Mitotic Fidelity
Lee M. Bergman et al.
MOLECULAR AND CELLULAR BIOLOGY (2009)
In vivo activity of novel capecitabine regimens alone and with bevacizumab and oxaliplatin in colorectal cancer xenograft models
Kenneth Kolinsky et al.
MOLECULAR CANCER THERAPEUTICS (2009)
Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources
Da Wei Huang et al.
NATURE PROTOCOLS (2009)
Mesenchymal stem cells within tumour stroma promote breast cancer metastasis
Antoine E. Karnoub et al.
NATURE (2007)
Phosphodiesterase-5 inhibition augments endogenous antitumor immunity by reducing myeloid-derived suppressor cell function
Paolo Serafini et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2006)
The effect of different doses of cisplatin on the pharmacokinetic parameters of cefepime in mice
Andras Mathe et al.
LABORATORY ANIMALS (2006)
Phosphodiesterase 5 inhibitors in the treatment of erectile dysfunction
Antonio Aversa et al.
CURRENT PHARMACEUTICAL DESIGN (2006)
The stroma reaction myofibroblast: a key player in the control of tumor cell behavior
A Desmouliere et al.
INTERNATIONAL JOURNAL OF DEVELOPMENTAL BIOLOGY (2004)
The phosphodiesterase inhibitory selectivity and the in vitro and in vivo potency of the new PDE5 inhibitor vardenafil
IS de Tejada et al.
INTERNATIONAL JOURNAL OF IMPOTENCE RESEARCH (2001)
Share Paper
